The cysteine protease inhibitor SN has been shown to recruit members of the ovarian tumor domain-containing cysteine protease superfamily, reduce GPX4 ubiquitination, lower ROS levels, and inhibit ferroptosis in gastric cancer cells [56]. Here, GPX4 is linked to ovarian neoplasm.